News from american society of hematology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 12, 2022, 14:56 ET Studies Focus on Optimizing Pediatric Care from Birth to Adulthood

New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition draws attention to previously overlooked...

Dec 10, 2022, 12:56 ET Research Highlights Cutting-Edge New Treatments for Blood Disorders

New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches for...

Dec 10, 2022, 11:48 ET New Studies Challenge the Dogma of Blood Cancer Care

esearch findings being presented during the 64th American Society of Hematology (ASH) Annual Meeting and Exposition challenge standard practices in...

Dec 10, 2022, 09:49 ET Research Exposes Inequities in Health Care Access and Delivery for Blood Disorders

Four studies presented during the 64th American Society of Hematology (ASH) Annual Meeting and Exposition uncover significant disparities in medical...

Jun 06, 2022, 11:38 ET ASH Announces Institutions Selected for the Innovative Hematology-Focused Fellowship Training Program

Today, the American Society of Hematology (ASH) announced the institutions that have been selected for the ASH Hematology-Focused Fellowship Training ...

Dec 14, 2021, 09:00 ET Fitusiran Substantially Reduces Hemophilia Bleeds with Simple Monthly Injection

Fitusiran, an experimental hemophilia therapy administered through a monthly subcutaneous injection, met its primary endpoint in a phase III trial...

Dec 14, 2021, 09:00 ET Pola-R-CHP Drug Combination Outperforms Standard R-CHOP Regimen for Diffuse Large B-cell Lymphoma for Progression-free Survival at Two Years

A new trial found patients with diffuse large B-cell lymphoma (DLBCL) had a significantly higher likelihood of survival without disease progression...

Dec 14, 2021, 09:00 ET CAR T-cell Therapy Found Equivalent to Standard of Care as Second-line Treatment for Aggressive non-Hodgkin Lymphoma

In a phase III trial presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, the chimeric antigen receptor...

Dec 11, 2021, 12:30 ET COVID-19 Takes a Toll on People with Blood Cancers and Disorders

As the COVID-19 pandemic continues to evolve, five studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and...

Dec 11, 2021, 10:30 ET Studies Highlight Novel Approaches to Screening for and Treating Blood Disorders

Three studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition throw a spotlight on novel...

Dec 11, 2021, 08:30 ET New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers

Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition point to the transformative role...

Dec 11, 2021, 07:00 ET Research Uncovers Gaps and Opportunities in Acute Leukemia Care Across the Lifespan

Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition highlight opportunities to better...

Dec 02, 2021, 08:00 ET GBT Supports the ASH Research Collaborative's Data Hub Sickle Cell Disease Program

The ASH Research Collaborative (ASH RC), a non-profit organization established in 2018 by the American Society of Hematology (ASH), and Global Blood...

Aug 16, 2021, 10:41 ET ASH Research Collaborative Announces First Ten Clinical Trial Consortia to Join the Sickle Cell Disease Clinical Trials Network

The ASH Research Collaborative (ASH RC) has announced the first 10 clinical research consortia to join the ASH RC Sickle Cell Disease Clinical Trials ...

Jan 12, 2021, 13:07 ET Organizations Collaborate to Develop International State-of-the-Art Guidelines on the Diagnosis and Management of von Willebrand Disease

The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and...

Dec 08, 2020, 12:05 ET Gene Therapy for Hemophilia B Found Safe and Effective in First Phase III Trial

The gene therapy etranacogene dezaparvovec substantially increased production of the blood clotting protein factor IX among 52 patients in the...

Dec 08, 2020, 12:05 ET Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis

Genetic mutations linked with cancer can occur during childhood or even before birth and proliferate in the body for many years before causing cancer ...

Dec 08, 2020, 12:04 ET Asciminib Found Safe and Effective for Hard-to-Treat Chronic Myeloid Leukemia

In a phase III trial called ASCEMBL, the experimental drug asciminib was nearly twice as effective as a standard-of-care treatment regimen for...

Dec 05, 2020, 12:46 ET Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Three studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition report promising results in the use...

Dec 05, 2020, 11:00 ET Hematologists Play Vital Role in Advancing COVID-19 Research, Potential Treatments

There are now millions of cases worldwide of COVID-19 infection, caused by the new virus SARS-CoV-2. As cases continue to soar, researchers around...

Dec 04, 2020, 13:07 ET Clinical Trials Offer Opportunities to Change Practice to Improve Prevention and Treatment of Blood Disorders

Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition present opportunities to improve care ...

Dec 04, 2020, 11:19 ET New Studies Call Attention to Effects of Structural Inequities on Health in America

Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition highlight the ways disparities and...

Oct 08, 2020, 13:05 ET ASH Releases Clinical Practice Guidelines on the Use of Preventive Anticoagulation in Patients with COVID-19

Today, ASH released new guidelines to help clinicians prevent serious blood clotting complications affecting COVID-19 patients. The recommendations...

Aug 12, 2020, 13:33 ET New Recommendations Aim to Increase Capacity for Specialized Care for Adults Living with Sickle Cell Disease

Across the United States, adults with sickle cell disease (SCD) lack access to comprehensive care to manage their condition, help them prevent...

Aug 06, 2020, 12:04 ET ASH Releases New Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults

Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care...